Were any Triaminic® products affected by the voluntary removal of Infant cold and cough products from the U.S. market?
Yes. On October 11, 2007, Novartis Consumer Health, Inc., along with other U.S. industry manufacturers, voluntarily removed Infant cold and cough products as a precautionary measure to avoid consumer misuse, including unintentional overdose in infants under age two. Specifically, Novartis Consumer Health, Inc. voluntarily removed the following two products from the market: Triaminic® Infant and Toddler Thin Strips® Decongestant and Triaminic® Infant and Toddler Thin Strips® Decongestant Plus Cough.
Related Questions
- Why did Health Canada not recommend the removal of ProHeart6 from the Canadian market immediately following the voluntary recall of this veterinary drug in the US?
- Should all children’s oral cough and cold medicines be withdrawn from the market?
- When Kroger expands its voluntary recall of beef, how many products are affected?
